Mobile health technology to help people quit smoking in Laos
Official title: Mobile Health Technology for Personalized Tobacco Cessation Support in Laos
Run by University of Oklahoma · NCT05233228 · Data updated 2026-11-12
This study is testing a mobile app designed to help people in Laos quit smoking by providing personalized support and resources.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University of Oklahoma Academic / other |
| Locations | 2 sites (Champasak and 1 other locations) |
| Status | Recruiting |
| Started | April 27, 2022 |
| Main results expected | August 31, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | August 15, 2025 |
| Trial ID | NCT05233228 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are current smokers and planning to quit within the next six months.
✕Probably not a fit
Patients with medical conditions that prevent the use of nicotine replacement therapy or those currently enrolled in other cessation programs may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to develop and evaluate a mobile health (mHealth) intervention tailored for tobacco cessation in Laos, where smoking rates are notably high. The study consists of two main phases: the first phase involves formative research to adapt the intervention content to the local sociocultural context, while the second phase will implement a randomized controlled trial to assess the effectiveness of the intervention. The mHealth approach includes a smartphone-delivered, automated, and personalized behavioral treatment using the Insight™ platform. The goal is to create a sustainable and widely adoptable solution for smoking cessation in the region.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce smoking rates and improve public health outcomes in Laos.
How similar studies have gone: Other studies utilizing mobile health interventions for smoking cessation have shown promising results, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: (pilot RCT in the R21 Phase and main RCT in the R33 Phase): 1. aged ≥18 years 2. self-reported current combustible cigarette smokers (smoked at least 100 cigarettes in lifetime and currently smoke ≥1 cigarette/day) 3. willing to set a quit date within 2 weeks of study enrollment 4. able to provide written informed consent to participate 5. able to read Lao (score ≥4 points on the Rapid Estimate of Adult Literacy in Medicine-Short Form). Exclusion Criteria: (pilot RCT in the R21 Phase and main RCT in the R33 Phase) 1. history of a medical condition that precludes use of NRT 2. ineligibility to participate based on medical or psychiatric conditions diagnosed by a physician/clinician 3. enrollment in another cessation program or current use of other cessation medications.
Where it's running
-
Champasak Hospital
Champasak, Laos Recruiting -
Setthathirath Hospital
Vientiane, Laos Recruiting
Study contacts
- Study coordinator: Thanh C Bui, MD, DrPH
- Email: thanh-c-bui@ouhsc.edu
- Phone: +1-713-474-6040
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Choice-based harm-reduction sampling to help people not ready to quit smoking
This project will test whether letting smokers who aren't ready to quit choose and try a harm-reduction product (an e-cigarette or a nicotine pouch) leads to less cigarette use over six months than giving a nicotine patch plus lozenge.
-
How a very-low-nicotine cigarette standard and product prices affect illegal cigarette buying
This study will test whether requiring very-low-nicotine cigarettes and changing e-cigarette or illegal cigarette prices changes illegal cigarette buying and use of alternatives among adult smokers and dual users.
-
How different tobacco tax plans and availability of regular versus low-nicotine cigarettes affect what smokers buy in a virtual marketplace
This project tests whether four different tobacco tax proposals and the presence or absence of regular (normal-nicotine) cigarettes change purchasing choices among adult daily smokers in a simulated marketplace.
-
Quit-smoking support for fathers of sick children
This project will try a proactive program of brief advice, free nicotine replacement sampling, and smartphone counselling to help fathers of sick children stop smoking.
-
Varenicline-based approach to help Veterans who smoke see if they can reduce smoking and try to quit
This study tests whether varenicline, plus motivational support, helps Veterans who aren’t ready to quit reduce smoking and make quit attempts.
-
Evaluating nicotine pouches for quitting smoking
This study is testing if tobacco-free nicotine pouches can help smokers switch from cigarettes by trying out different nicotine levels over 28 days.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.